- Home
- DXST vs HOTH Comparison
DXST vs HOTH Comparison
Compare DXST & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXST
- HOTH
- Stock Information
- Founded
- DXST 2011
- HOTH 2017
- Country
- DXST China
- HOTH United States
- Employees
- DXST N/A
- HOTH N/A
- Industry
- DXST
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- DXST
- HOTH Health Care
- Exchange
- DXST NYSE
- HOTH Nasdaq
- Market Cap
- DXST 18.7M
- HOTH 15.6M
- IPO Year
- DXST 2025
- HOTH 2019
- Fundamental
- Price
- DXST $1.34
- HOTH $1.27
- Analyst Decision
- DXST
- HOTH Strong Buy
- Analyst Count
- DXST 0
- HOTH 3
- Target Price
- DXST N/A
- HOTH $4.00
- AVG Volume (30 Days)
- DXST 35.1K
- HOTH 541.8K
- Earning Date
- DXST 01-01-0001
- HOTH 05-12-2025
- Dividend Yield
- DXST N/A
- HOTH N/A
- EPS Growth
- DXST 13.11
- HOTH N/A
- EPS
- DXST 0.14
- HOTH N/A
- Revenue
- DXST $11,542,292.00
- HOTH N/A
- Revenue This Year
- DXST N/A
- HOTH N/A
- Revenue Next Year
- DXST N/A
- HOTH N/A
- P/E Ratio
- DXST $9.25
- HOTH N/A
- Revenue Growth
- DXST 22.18
- HOTH N/A
- 52 Week Low
- DXST $0.85
- HOTH $0.58
- 52 Week High
- DXST $5.74
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- DXST N/A
- HOTH 56.14
- Support Level
- DXST N/A
- HOTH $1.29
- Resistance Level
- DXST N/A
- HOTH $1.57
- Average True Range (ATR)
- DXST 0.00
- HOTH 0.09
- MACD
- DXST 0.00
- HOTH -0.00
- Stochastic Oscillator
- DXST 0.00
- HOTH 52.07
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).